MedTrace Logo

Plasma Concentration of Biological Markers in Placenta Accreta Spectrum

NCT04525534 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2024-09-03

No results posted yet for this study

Summary

The purpose of this exploratory study is to determine how well maternal serum biomarkers and placental micro-particles (MP) correlate with placenta accreta spectrum (PAS) at the time of cesarean delivery in women with suspected PAS compared to women without PAS. Our aim is to determine if women with PAS have a unique MP and protein signature at the time of delivery compared with women without PAS.

Conditions

  • Placenta Accreta
  • Placenta Diseases

Interventions

OTHER

There is no other intervention, only clinical treatment.

There is no other intervention, only clinical treatment

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Nadir e Sharawi, MD · UAMS

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-30
Primary Completion
2023-07-10
Completion
2023-07-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04525534 on ClinicalTrials.gov